# Cogent Therapeutics, LLC

- Location (FDA's records): Pleasanton, CA
- FDA decisions: 1 (2012–2012): 1 510(k) clearance
- Product codes: LYA (1)
- Predicates its devices cite: 5 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Medtronic Xomed, Inc.: 2 (https://510kreport.com/company/medtronic-xomed)
- Polyganics B.V.,: 1 (https://510kreport.com/company/polyganics)
- Genzyme Corp.: 1 (https://510kreport.com/company/genzyme)
- Boston Medical Products, Inc.: 1 (https://510kreport.com/company/boston-medical-products)

## Firms that cite its devices most
- Arthrocare Corp.: 1 (https://510kreport.com/company/arthrocare)
- Medtronic, Inc.: 1 (https://510kreport.com/company/medtronic)
- Hemostasis, LLC: 1 (https://510kreport.com/company/hemostasis)

## Its most-cited devices
- K113585: Nasal/Epistaxis Pack (2012), cited by 3

## Recent decisions
- K113585: Nasal/Epistaxis Pack (Apr 25, 2012)

Source page: https://510kreport.com/company/cogent-therapeutics